Associate Director, Medical Products Research and Development, Cambridge Isotope Laboratories Inc.
Dr. Anil Modak, the Associate Director of Medical Products Research & Development at Cambridge Isotope Laboratories Inc.in Teksbury, MA, has been involved in the design, research and development of novel non invasive breath tests for personalized medicine using stable isotope substrates for the diagnosis of disease states and evaluation of enzyme activity. He is the author of several recent patents and publications and several presentations around the world. He has reviewed several papers for reputed journals and authored two book chapters. He serves on the Editorial board of the Journal of Breath Research, Journal of Pharmacogenomics & Pharmacoproteomics and International Journal of Clinical Pharmacology & Toxicology.
His previous experience includes working for Ribozyme Pharmaceuticals in Boulder, CO and Monsanto in St Louis, MO. His postdoctoral research was conducted at the University of Iowa and Kings College London.
Design and develop novel, non invasive, phenotype breath tests using stable isotope substrates for identifying responders/non responders for various drugs metabolized by specific polymorphic P450 CYP enzymes to enable physicians personalize medication for patients.